Fennec Pharmaceuticals Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Fennec Pharmaceuticals stock have an average target of 13, which predicts a 59.90% increase from the current stock price of 8.13.

Price Target: $13.00 (+59.90%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$13	$13	$13	$13
Change	+59.90%	+59.90%	+59.90%	+59.90%

Analyst Ratings

The average analyst rating for Fennec Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25	May '25
Strong Buy	2	2	2	2	2	2
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $13	Strong Buy	Reiterates	$13	+59.90%	May 20, 2025
Chase Knickerbocker Craig-Hallum	Craig-Hallum	Strong Buy Maintains $12 → $13	Strong Buy	Maintains	$12 → $13	+59.90%	May 14, 2025
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $13	Strong Buy	Reiterates	$13	+59.90%	Mar 11, 2025
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $13	Strong Buy	Reiterates	$13	+59.90%	Dec 17, 2024
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $15 → $13	Strong Buy	Maintains	$15 → $13	+59.90%	Aug 22, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

46.89M

from 47.54M

-1.37%

from 47.54M

Revenue Next Year

74.38M

from 46.89M

58.65%

from 46.89M

EPS This Year

0.10

from -0.02

EPS Next Year

1.07

from 0.10

923.39%

from 0.10

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	170.00K	-	1.54M	21.25M	47.54M	46.89M	74.38M	94.95M
Revenue Growth	-	-	-	1,284.50%	123.69%	-1.37%	58.65%	27.65%
EPS	-0.76	-0.67	-0.90	-0.60	-0.02	0.10	1.07	1.83
EPS Growth	-	-	-	-	-	-	923.39%	71.11%
Forward PE	-	-	-	-	-	77.69	7.59	4.44
No. Analysts	-	-	-	-	-	7	7	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	54.1M	92.1M	110.5M
Avg	46.9M	74.4M	94.9M
Low	35.5M	65.2M	80.5M

Revenue Growth

Revenue Growth	2025	2026	2027
High	13.9%	96.5%	48.6%
Avg	-1.4%	58.6%	27.6%
Low	-25.2%	39.0%	8.3%

EPS Forecast

EPS	2025	2026	2027
High	0.58	2.31	2.98
Avg	0.10	1.07	1.83
Low	-0.27	0.62	0.92

EPS Growth

EPS Growth	2025	2026	2027
High	-	2,107.3%	178.4%
Avg	-	923.4%	71.1%
Low	-	490.0%	-14.0%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.